August 7, 2008
    Print this page +1    +2    +3      Standard Text
    Overview
    Signs & Symptoms
    Screening and diagnosis
    Treatments
    Clinical Trials
    People
    Bladder Cancer Research
    Center
    Screening and Detection
    New Drug Development
    & Treatment for superficial
    Bladder Cancer
    Surgical Innovation in
    Management of Invasive
    Bladder Cancer
    Exploring Treatment for
    Bladder Cancer
    Bladder Preserving Therapies
    Symptom Management
    and Quality of Life Issues
    Books/Articles
    Audio/Video Resources
    Related Links
    Meeting Tracker
   


BOOKS/ARTICLES


Books


Articles

  • Histone Deacetylase Inhibitors Up-Regulate Expression Of The Coxsackie Adenovirus Receptor (CAR) Preferentially In Bladder Cancer Cells. Sachs, M., Ramamurthy, M., van der Poel, H., Wickham, T., Lamfers, M., Gerritsen, W., Chowdhury, W., Li, Y., Schoenberg, M., and Rodriguez, R.

    We have discovered that a certain class of drugs (Histone Deacetylase Inhibitors) can cause bladder cancer cells to express a receptor which is commonly lost during its transition to an invasive malignancy. This finding has profound ramifications for gene therapy of bladder cancer, and may have implications for a potential strategy for chemoprevention of invasiveness.

  • Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer. Van Der PoelL HG, Molenaar B, Van Beusechem VW, Haisma HJ, Rodriguez R, Curiel DT, Gerritsen WR

  • Integrin Alpha-V and Coxsackie-Adenovirus Receptor (CAR) in Clinical Bladder Cancer Sachs, M, Rauen, KA, Ramamurthy, M, Dodson, J, De Marzo AM, Putzi, MJ, Schoenberg, MP, Rodriguez, R



© Copyright 2008 | All Rights Reserved | Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287